Reverse Splits

[e-ore]

KDRH - Planning 1 for 6 r/s as part of share exchange agreement

"The Agreement further provides that the Registrant: (i) file a registration statement on Form S-1 for the purpose of registering the Post-Reverse Shares issuable to the BioPharma Shareholders, subject to certain limitations; (ii) file an Information Statement on Schedule 14C with the SEC providing for a reverse split of the Registrant's 22,710,192 presently issued and outstanding shares of common stock on a one-for-six (1:6) basis, among other corporate actions; and (iii) apply for and receive approval from FINRA regarding the corporate actions. "

http://archive.fast-edgar.com//20170809/AFKZQ22CZ22TF2Z2222F2MZMA3NMZZ224U92/